PharmaTimesNews & Politicsnews

FDA approves Leqembi Iqlik subcutaneous initiation dose for Alzheimer’s disease

Tuesday, July 14, 2026John PinchingView original

At‑home autoinjector option offers new flexibility for patients and care partners

Read the full article on the original site.